New York A05354 requires health insurers to cover opioid antagonists and devices without cost-sharing and prohibits prior authorization or premedical.

New York A05354 amends the insurance law to mandate that health insurers provide coverage for at least one opioid antagonist and device without any cost-sharing. An opioid antagonist is defined as a drug approved by the Food and Drug Administration that negates or neutralizes the effects of opioids in the body. The coverage must include opioid antagonists prescribed or dispensed via standing order or collaborative practice agreement. The bill also prohibits any prior authorization or premedical review for coverage of opioid antagonists.

New York A05354 requires health insurers to cover opioid antagonists and devices without cost-sharing and prohibits prior authorization or premedical.

New York A05354 amends the insurance law to mandate that health insurers provide coverage for at least one opioid antagonist and device without any cost-sharing. An opioid antagonist is defined as a drug approved by the Food and Drug Administration that negates or neutralizes the effects of opioids in the body. The coverage must include opioid antagonists prescribed or dispensed via standing order or collaborative practice agreement. The bill also prohibits any prior authorization or premedical review for coverage of opioid antagonists.